ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

CA

Centre Antoine Lacassagne at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Centre Antoine Lacassagne takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans breast and prostate cancer treatment. It examines treatment choices after breast cancer returns during or after preventive therapy, alongside real-world outcomes in early breast cancer and prostate cancer.

OrganizationESMO 2026 Attendance
CA
Centre Antoine Lacassagne
Nice, France
Cancer centre & hospital
Regional comprehensive cancer centre of the French Unicancer network in Nice, France.
Satellite
Mon Oct 26
13:45–14:05
Clinical decision point 3: How should first-line treatment be selected following recurrence on an adjuvant CDK4/6 inhibitor?
Novartis - From Risk to Recurrence: Personalizing CDK4/6 Inhibitor Strategies in HR+/HER2− Breast Cancer
Breast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Centre Antoine Lacassagne

Tell us what you sell and we’ll find the people at Centre Antoine Lacassagne most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction